Literature DB >> 26610780

Surgical Management of Adrenocortical Carcinoma: An Evidence-Based Approach.

Jashodeep Datta1, Robert E Roses2.   

Abstract

Adrenocortical carcinoma frequently presents with sequelae of steroid precursor overproduction and has a proclivity for aggressive local growth, early metastasis, and recurrence. En bloc surgical resection with negative margins is the cornerstone of therapy for localized disease, and re-resection has a role in selected recurrent cases. Presence of occult micrometastatic disease at the time of presentation is confirmed by frequent distant failure after apparent negative margin resection. Data for many aspects of therapy are limited or nonexistent. This review critically considers existing evidence with a particular focus on surgical management.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenalectomy; Adrenocortical carcinoma; Laparoscopic; Localized; Metastatic; Multimodality; Recurrence; Surgery

Mesh:

Year:  2015        PMID: 26610780     DOI: 10.1016/j.soc.2015.08.011

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  5 in total

1.  Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?

Authors:  Jon M Gerry; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Jason D Prescott; Tracy S Wang; Jason A Glenn; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; Ioannis Hatzaras; Rivfka Shenoy; Timothy M Pawlik; Jeffrey A Norton; George A Poultsides
Journal:  Ann Surg Oncol       Date:  2016-09-02       Impact factor: 5.344

Review 2.  Adrenalectomy for Cushing's syndrome: do's and don'ts.

Authors:  D N Paduraru; A Nica; M Carsote; A Valea
Journal:  J Med Life       Date:  2016 Oct-Dec

3.  A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study.

Authors:  Jianqiu Kong; Junjiong Zheng; Jinhua Cai; Shaoxu Wu; Xiayao Diao; Weibin Xie; Xiong Chen; Chenyi Liao; Hao Yu; Xinxiang Fan; Chaowen Huang; Zhuowei Liu; Wei Chen; Qiang Lv; Haide Qin; Jian Huang; Tianxin Lin
Journal:  Cancer Commun (Lond)       Date:  2019-11-27

4.  Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.

Authors:  Zhengqing Yang; Hui Cheng; Yazhou Zhang; Yan Zhou
Journal:  Med Sci Monit       Date:  2021-03-05

Review 5.  The Immunotherapy Landscape in Adrenocortical Cancer.

Authors:  Guillaume J Pegna; Nitin Roper; Rosandra N Kaplan; Emily Bergsland; Katja Kiseljak-Vassiliades; Mouhammed Amir Habra; Yves Pommier; Jaydira Del Rivero
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.